ImmuCell Corporation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
ImmuCell Corporation (ICCC) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $398 for the 12-month period ending 2013-12-31, per its 10-K filed 2015-03-26.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2015-03-26
- ImmuCell Corporation adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2012-12-31 was $419.00, a 55.89% decline year-over-year.
- ImmuCell Corporation adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- ImmuCell Corporation adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2012-06-30 was $0.00.
- ImmuCell Corporation adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2012-03-31 was $6.84K.
- ImmuCell Corporation adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2013 was $398.00, a 94.52% decline from fiscal 2012.
- ImmuCell Corporation adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2012 was $7.26K, a 49.99% decline from fiscal 2011.
- ImmuCell Corporation adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2011 was $14.52K.
- ImmuCell Corporation adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2009 was $921.00.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 3 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 6 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 9 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month |
|---|---|---|---|---|
| 2013-12-31 | $398.00 10-K · filed 2015-03-26 | |||
| 2012-12-31 | $419.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $419.00 derived: sum of 2 quarters · filed 2015-03-26 | $419.00 derived: sum of 3 quarters · filed 2015-03-26 | $7.26K 10-K · filed 2015-03-26 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $0.00 derived: sum of 2 quarters · filed 2013-11-13 | $6.84K 10-Q · filed 2013-11-13 | $7.79K derived: sum of 4 quarters · filed 2014-03-26 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $6.84K 10-Q · filed 2013-08-13 | $7.79K derived: sum of 3 quarters · filed 2014-03-26 | $13.96K derived: sum of 4 quarters · filed 2014-03-26 |
| 2012-03-31 | $6.84K 10-Q · filed 2013-05-14 | $7.79K derived: sum of 2 quarters · filed 2014-03-26 | $13.96K derived: sum of 3 quarters · filed 2014-03-26 | |
| 2011-12-31 | $950.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $7.11K derived: sum of 2 quarters · filed 2014-03-26 | $14.52K 10-K · filed 2014-03-26 | |
| 2011-09-30 | $6.16K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-13 | $13.57K 10-Q · filed 2012-11-13 | ||
| 2011-06-30 | $7.40K 10-Q/A · filed 2012-09-07 | |||
| 2009-12-31 | $921.00 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |